Drugs / Trishul
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07430696 | May 2026 → May 2027 expected | — | University of Kelaniya | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trishul | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07430696 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “anticancer ayurvedic drug Trishul” NCT07430696 ↗ |
| Route | Oral | “750 mg of the drug orally” NCT07430696 ↗ |